Arrakis Therapeutics Stock

arrakistx.comBioTechFounded: 2015Funding to Date: $113.5MM

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA.

Register for Details

For more details on financing and valuation for Arrakis Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Jennifer Petter Ph.D
Co-Founder & Chief Scientific Officer
Daniel Koerwer
Chief Business Officer
Alan Walts Ph.D
Co-Founder & Board Member
Rajesh Parekh Ph.D
Co-Founder & Board Member
James Barsoum Ph.D
Senior Vice President of Biology
Heather Lounsbury
Vice President of Business & Technical Operations
Michael Gilman Ph.D
Chief Executive Officer & Chairman
Henri Termeer
Co-Founder

Board Members

Alan Walts Ph.D
Carolyn Green
Colleen Cuffaro Ph.D
Canaan Partners
Elaine Jones Ph.D
Pfizer Ventures
Jakob Loven Ph.D
Nextech Invest
Matthew Cohen Ph.D
Osage Venture Partners
Michael Gilman Ph.D
Nikola Trbovic Ph.D
Pfizer Ventures
Peter Worland Ph.D
Celgene
Rajesh Parekh Ph.D
Richard Gaster MD
venBio
Timothy Shannon MD
Canaan Partners

Other companies like Arrakis Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM